Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant HBV-B HBsAg Protein, N-His

Catalog #:   YVV03001 Specific References (21) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q67926
Protein length: Met1-Arg253
Overview

Catalog No.

YVV03001

Expression system

E. coli

Species

Hepatitis B virus genotype B2 subtype adw (isolate China/patient4/1996) (HBV-B)

Protein length

Met1-Arg253

Predicted molecular weight

29.11 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q67926

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant HBV-B HBsAg Protein
References

Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda., PMID:34043637

Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection., PMID:32336003

Treatment of hepatitis D: an unmet medical need., PMID:32120043

Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term., PMID:30924226

Different pre-S deletion patterns and their association with hepatitis B virus genotypes., PMID:27672298

[Clinical emergence features and implications of hepatitis B virus rtA181T mutation]., PMID:25751382

Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injection., PMID:24618716

High prevalence of hepatitis B virus genotype C/C1 in the Minangkabau ethnic group in Indonesia., PMID:23336976

Hepatitis B virus pre-S2 start codon mutations in Indonesian liver disease patients., PMID:23082059

High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China., PMID:22941290

HBV/D1: a major HBV subgenotype circulating in Uyghur patients with chronic HBV infection in Xinjiang, China., PMID:22610589

Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China., PMID:22500577

Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy., PMID:22267471

Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection., PMID:22086128

Low prevalence of hepatitis B virus pre-S deletion mutation in Indonesia., PMID:21837787

HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines., PMID:21484121

Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey., PMID:20723037

[Changes of serum HBsAg in HBeAg positive chronic hepatitis patients with sustained viral response to long-term lamivudine treatment]., PMID:18578990

Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia., PMID:18463220

Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia., PMID:18207274

Genotypic dominance and novel recombinations in HBV genotype B and C co-infected intravenous drug users., PMID:15042642

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant HBV-B HBsAg Protein, N-His [YVV03001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only